Cardiome Pharma Corp., of Vancouver, British Columbia, filed a prospectus supplement pertaining to sales under a January purchase agreement with Lincoln Park Capital Fund LLC (LPC) and a separate prospectus supplement pertaining to sales under a February at-the-market (ATM) sales agreement with MLV & Co. LLC.